<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Autoimmune thyroid disorders":1,
"Graves’ disease":1,
"Hashimoto’s thyroiditis":1,
"Immunity":1,
"Thyroid cancer":17,
"BRAF V600E":2,
"TERT promoter mutation":1,
"radioiodine therapy":1,
"recurrence":4,
"Macrocalcification":1,
"Microcalcification":1,
"Thyroid carcinoma":12,
"Ultrasonography":5,
"123I":1,
"131I":1,
"nasolacrimal duct obstruction":1,
"papillary thyroid carcinoma":26,
"allostery":1,
"cancer":1,
"enzymology":1,
"mutation":1,
"NGS":1,
"PPARG and RET rearrangements":1,
"follicular carcinoma":1,
"macrofollicular variant":1,
"thyroid":9,
"Clostridium&nbsp":1,
"perfringens enterotoxin":1,
"claudins":1,
"directed mutagenesis":1,
"lung cancer":3,
"necrosis":1,
"Chronic mercury intoxication":1,
"Metallic mercury":1,
"Selenium":1,
"Thyroid ultrasound":2,
"Thyroxine":1,
"Diarrhoea":1,
"Hypertension":1,
"Lenvatinib":2,
"Practical management":1,
"Proteinuria":1,
"adverse event":1,
"gallbladder":1,
"toxicity":1,
"tyrosine kinase inhibitor":1,
"postprogression survival":1,
"real-world analysis":1,
"PCR-RFLP":1,
"p21":1,
"p53":2,
"papillary thyroid cancer":7,
"polymorphisms":1,
"tumor":1,
"ACC":1,
"adrenal cancer":1,
"cabozantinib":1,
"tyrosine kinase inhibitors":1,
"management":1,
"retropharyngeal lymph node metastasis":1,
"surgery":4,
"transoral robotic surgery":1,
"Differentiated thyroid cancer":1,
"Pediatric papillary thyroid carcinoma":1,
"Recurrence predictors":1,
"Adjuvant":1,
"Radioactive iodine":1,
"Thyroidectomy":7,
"TNM":1,
"age":1,
"carcinoma":2,
"elderly":1,
"Cirugía":1,
"Iodine-131":1,
"Neoplasias de tiroides":1,
"Thyroid neoplasms":6,
"Tiempo":1,
"Time":1,
"Yodo-131":1,
"Complication":1,
"Corpectomy":1,
"Elderly patients":1,
"Hemivertebrectomy":1,
"Spinal metastasis":1,
"Spondylectomy":1,
"Survival analysis":1,
"Lateral lymph node metastasis":1,
"Predictive model":1,
"Risk stratification":1,
"Treatment strategy":1,
"CTH":1,
"H2S":1,
"NF-κB":1,
"diallyl trisulfide":1,
"adjuvant chemotherapy":1,
"anaplastic thyroid carcinoma":2,
"combined modality therapy":1,
"head and neck cancer":2,
"radiation therapy":1,
"Metabolism":1,
"Sorafenib":1,
"Sorafenib-associated hypoglycaemia":1,
"Streptozotocin-induced diabetes":1,
"childhood cancer survivor":1,
"fine needle aspiration":1,
"secondary cancer":1,
"thyroid tumor":1,
"ultrasound":7,
"CK5/6":1,
"Raman spectrum analysis":1,
"SCCTh":1,
"Clinicopathological":1,
"Prediction":1,
"TERT promoter":2,
"Hepatitis B virus (HBV), mitochondria":1,
"interaction":1,
"proteins/signaling":1,
"activator protein-1":1,
"miRNA, papillary thyroid carcinoma":1,
"stanniocalcin-1":1,
"stress-activated protein kinase":1,
"medullary thyroid carcinoma":5,
"submandibular gland, metastases, ultrasound":1,
"central lymph nodes dissection":1,
"endoscopy thyroidectomy":1,
"nanocarbon":1,
"Lymph node metastasis":2,
"Prophylactic central lymph node dissection":2,
"Thyroid cancer recurrences":1,
"Total thyroidectomy":1,
"Hippo signaling pathway":1,
"follicular thyroid carcinoma":1,
"resveratrol":1,
"sialyltransferase families":1,
"PTC":3,
"TLR4":1,
"ceRNAs":1,
"circRASSF2":1,
"exosome":2,
"miR-1178":1,
"Multimodal treatment strategies":1,
"Novel therapies":1,
"Prognosis":4,
"Survival":3,
"BIRC7":1,
"EMT":1,
"autophagy":2,
"metastasis":4,
"mucinous breast carcinoma":1,
"fine-needle aspiration cytology":1,
"secondary thyroid neoplasm":2,
"Anterior chest approach":1,
"Cosmetic":1,
"Endoscopic thyroidectomy":2,
"Neck dissection":2,
"Clinical practice variation":1,
"Thyroid fine needle aspiration":1,
"Thyroid nodule":6,
"Carney complex":1,
"MEN":2,
"NF1":1,
"VHL":1,
"pancreatic cancer":1,
"Anaplastic thyroid cancer":1,
"Bioinformatics analysis":3,
"Differentially expressed genes":1,
"Quantitative real-time PCR":1,
"human papilloma virus":1,
"next-generation sequencing":1,
"papillary cystic carcinoma":1,
"papilloma":1,
"HMGB1":1,
"LncRNA ANRIL":1,
"Propofol":1,
"Wnt/β-catenin pathway":1,
"microRNA-320a":1,
"Breast cancer":5,
"Ductal carcinoma in situ":1,
"Prediction model":1,
"SLNB omission":1,
"Upstaging":1,
"2020":2,
"Adult":2,
"Bromocriptine":1,
"CT scan":2,
"Corticosteroids":1,
"Cytokeratin 7*":1,
"Diplopia":1,
"Dizziness":1,
"Dopamine agonists":1,
"FSH":1,
"Female":2,
"Fine needle aspiration biopsy":2,
"Glucocorticoids":1,
"Goitre":1,
"Goitre (multinodular)":1,
"Granuloma":1,
"Headache":1,
"Heart failure":1,
"Histopathology":2,
"Hydrocortisone":1,
"Hyperprolactinaemia":1,
"Hyponatraemia":1,
"Hypopituitarism":1,
"Immunohistochemistry":3,
"LH":1,
"Levothyroxine":1,
"Lymph node dissection":2,
"Lymphadenitis":1,
"Lymphadenopathy":1,
"MRI":1,
"March":1,
"Metastatic carcinoma":2,
"Mineralocorticoids":1,
"Normochromic normocytic anaemia":1,
"Oculomotor nerve palsies*":1,
"Paraesthesia":1,
"Pituitary adenoma":1,
"Pituitary function":1,
"Poland":1,
"Prolactin":2,
"Ptosis":1,
"Radionuclide imaging":1,
"Recombinant TSH*":1,
"Resection of tumour":1,
"Sarcoidosis":1,
"Sarcoidosis*":1,
"Sodium chloride":1,
"TSH":2,
"Thyroglobulin":2,
"Thyroid antibodies":1,
"Thyroid transcription factor-1":2,
"Thyroid ultrasonography":2,
"Transsphenoidal surgery":1,
"Ultrasound scan":2,
"Unique/unexpected symptoms or presentations of a disease":2,
"Ventricular fibrillation":1,
"Vision - acuity reduction":1,
"Visual impairment":1,
"Vomiting":1,
"White":1,
"Shear wave elastography":1,
"AR":1,
"MLPH":1,
"prognostic value":1,
"comparison":1,
"lymph nodes dissection":1,
"open thyroidectomy":1,
"AFIRMA":1,
"adrenocorticotropic hormone":1,
"estrogen":1,
"folliculo-stellate cells":1,
"microenvironment":1,
"pituitary gland":1,
"prolactinoma":1,
"rat":1,
"thyroid-stimulating hormone":1,
"active surveillance":1,
"low risk":1,
"papillary thyroid microcarcinoma":1,
"microcarcinoma":2,
"nonoperative":1,
"papillary":2,
"long non-coding RNA HOXA transcript at the distal tip":1,
"long non-coding RNA pre-ribosomal RNA antisense transcripts":1,
"proliferation":2,
"Alcohol":1,
"Brf1":1,
"Pol III genes":1,
"Runx2":1,
"EBV":1,
"NSG":1,
"graft-versus-host disease":1,
"lymphoma":1,
"mice":1,
"posttransplant lymphoproliferative diseases":1,
"cytoplasmic multiple Auer rods":1,
"fine﻿-needle aspiration":1,
"PI3K":1,
"apatinib":1,
"apoptosis":2,
"Brain metastasis":1,
"Papillary microcarcinoma":1,
"COVID-19":1,
"PET/CT":1,
"nuclear medicine":1,
"pneumonia":1,
"Li-Fraumeni syndrome":1,
"Radiation-induced malignancy":1,
"Radiotherapy":2,
"Anticancer compounds":1,
"Copper complexes":1,
"Nanomolar activity":1,
"Protein disulfide isomerase inhibitors":1,
"Thiosemicarbazones":1,
"X-ray structure":1,
"hospital volume":1,
"thyroid surgery":1,
"tumor size":1,
"Electrothermal bipolar vessel sealing devices":1,
"Energy devices":1,
"Postoperative complication":2,
"Ultrasonic coagulating shears":1,
"Calcitriol":1,
"vitamin D receptor":1,
"Small nucleolar RNA host gene 22":1,
"long noncoding RNA":3,
"microRNA":2,
"Lymph nodes":1,
"Risk":1,
"Triage":1,
"Isolated macrocalcification":1,
"Malignancy risk":1,
"Thyroid malignancy":1,
"MiR-451a":1,
"ZEB1":1,
"Colorectal cancer":1,
"Rectal cancer":1,
"Tumor-to-tumor metastasis":1,
"CEUS":1,
"Elastography":1,
"Head and neck":1,
"Parotid gland":2,
"giant fibroadenoma":1,
"giant juvenile fibroadenoma":1,
"inverted “T” incision":1,
"FOSL2":1,
"LINC00313":1,
"miR-342-3p":1,
"osteosarcoma (OS)":1,
"Antigen,CD56":1,
"Pathology, clinical":1,
"epidemiology":1,
"health policy":1,
"protocols &amp":1,
"guidelines":1,
"public health":1,
"Thyroid squamous cell carcinoma":1,
"endocrine surgery":1,
"oncology":1,
"SEER database":1,
"Survival factors":1,
"Thyroid Hurthle cell carcinoma":1,
"Blood vessel preservation":1,
"Lymph node excision":1,
"Parathyroid glands":1,
"Thyroid cancer, Papillary":1,
"Encapsulated angioinvasive follicular thyroid carcinoma":1,
"Formalin-fixed and paraffin-embedded samples":1,
"Microarray analysis":1,
"Minimally invasive follicular thyroid carcinoma":1,
"Laser":1,
"Nodule":1,
"Thermal ablation":1,
"Primary squamous cell carcinoma (PSCC)":1,
"case report":2,
"treatment":1,
"PIWI-interacting RNAs":1,
"biomarkers":2,
"diagnosis":3,
"nomogram":1,
"Central Neck Dissection":1,
"Locoregional Recurrence":1,
"Lymph Node":1,
"Favorable outcome":1,
"Human solid tumor":1,
"Meta-analysis":1,
"Tumor-associated tissue eosinophilia":1,
"nasopharynx":1,
"prominent spindle cell component":1,
"thyroid-like low-grade nasopharyngeal papillary adenocarcinoma":1,
"DSS":1,
"OS":1,
"RFS":1,
"SCCHN":1,
"body mass index":1,
"aus/flus":1,
"bethesda":1,
"risk of malignancy":1,
"thyroid nodules":1,
"ti-rads":1,
"Association-study":1,
"MTC":1,
"RET":1,
"SNP":1,
"extrathyroidal extension":1,
"transcription factor":1,
"weighted gene co-expression network analysis":1,
"population-based cohort study":1,
"uterine fibroids":1,
"BRAFV600E mutation":1,
"level V lymph nodes metastasis":1,
"pathological features":1,
"Granular cell tumor":1,
"Magnetic resonance imaging findings":1,
"Neurohypophysis":1,
"Pituicyte":1,
"Thyroid transcription factor 1":1,
"cancer diagnosis":1,
"liquid biopsy":1,
"miRNA":2,
"Gastrointestinal stromal tumour (GIST)":1,
"KIT mutation":1,
"PDGFRA":1,
"Protein kinase C theta (PKCθ)":1,
"BRAF":1,
"Molecular typing":1,
"Mutation rate":1,
"atezolizumab":1,
"checkpoint inhibition":1,
"immunotherapy":1,
"metastatic urothelial carcinoma":1,
"nivolumab":1,
"pembrolizumab":1,
"hepatocellular carcinoma":1,
"hypothyroidism":1,
"therapeutic target":1,
"thyroid hormone":1,
"thyroid hormone receptor":1,
"ACC, adrenocortical carcinoma":1,
"BLCA, bladder urothelial carcinoma":1,
"BRCA, breast invasive carcinoma":1,
"CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma":1,
"CHOL, cholangiocarcinoma":1,
"COAD, colon adenocarcinoma":1,
"ESCA, esophageal carcinoma":1,
"Function":1,
"GBM, glioblastoma multiforme":1,
"HNSC, head and neck squamous cell carcinoma":1,
"IsomiR":1,
"KICH, kidney chromophobe":1,
"KIRC, kidney renal clear cell carcinoma":1,
"KIRP, kidney renal papillary cell carcinoma":1,
"LAML, acute myeloid leukemia":1,
"LGG, brain Lower grade glioma":1,
"LIHC, liver hepatocellular carcinoma":1,
"LUAD, lung adenocarcinoma":1,
"LUSC, lung squamous cell carcinoma":1,
"Let-7":1,
"MESO, mesothelioma":1,
"MicroRNA (miRNA)":1,
"Network":1,
"OV, ovarian serous cystadenocarcinoma":1,
"PAAD, pancreatic adenocarcinoma":1,
"PCPG, pheochromocytoma and paraganglioma":1,
"PRAD, prostate adenocarcinoma":1,
"READ, rectum adenocarcinoma":1,
"SARC, sarcoma":1,
"SKCM, skin cutaneous melanoma":1,
"STAD, stomach adenocarcinoma":1,
"TGCT, testicular germ cell tumors":1,
"THCA, thyroid carcinoma":1,
"THYM, thymoma":1,
"TSG, tumor suppressor gene":1,
"UCEC, uterine corpus endometrial carcinoma":1,
"UCS, uterine carcinosarcoma":1,
"UVM, uveal melanoma":1,
"miR-10":1,
"ERα":1,
"ERβ":1,
"UHRF1":1,
"bilateral paratracheal sub-compartments":1,
"risk factors":2,
"tumor location":1,
"HDAC1":1,
"OSCC":1,
"PCNA":1,
"miR-154-5p":1,
"Hobnail variant":1,
"Rapid growth":1,
"lymph node metastases":1,
"Breast neoplasms":1,
"Induction chemotherapy":1,
"Receptor, ErbB-2":1,
"Trastuzumab":1,
"Cervical lymph node metastasis":1,
"Skip metastasis":1,
"Biopsy":2,
"Facial nerve":1,
"Neurilemmoma":1,
"Parotid region":1,
"Acromegaly":1,
"Insulin resistance":1,
"Leptin":1,
"Low-grade inflammation":1,
"Pituitary tumors":1,
"BRAF mutation":1,
"sonographic image":1,
"First postoperative day":1,
"Hypoparathyroidism":1,
"Prophylactic calcium supplementation":1,
"Severity":1,
"Cholangiocarcinoma":1,
"Diagnostic marker":1,
"Metastatic pancreatic ductal adenocarcinoma":1,
"PSMA":1,
"Peritumoral expression":1,
"Asian":1,
"cosmesis":1,
"minimally invasive video-assisted thyroidectomy":1,
"neck scar":1,
"RNA-Seq":1,
"bioinformatics":1,
"key gene":1,
"FNA":1,
"Suspicious for malignancy":1,
"Suspicious for non-papillary thyroid carcinoma":1,
"Suspicious for papillary thyroid carcinoma":1,
"The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)":1,
"Adrenal":1,
"Anastrozole":1,
"Anthracyclines":1,
"Asian - Filipino":1,
"August":1,
"Australia":1,
"Bone scintigraphy":1,
"Breast lump":1,
"Chemotherapy":1,
"Doxorubicin":1,
"Mammogram":1,
"Mastectomy":1,
"Oestrogens":1,
"PET scan":1,
"Paclitaxel":1,
"Progesterone":1,
"Radioiodine":1,
"Stereotactic radiosurgery":1,
"BRAFV600E":1,
"Snail-1":1,
"Hispanics":1,
"acculturation":1,
"financial burden":1,
"health care disparities":1,
"women":1,
"Chimeric flap":1,
"Gracilis muscle":1,
"Head and neck neoplasms":1,
"Myocutaneous flap":1,
"Perforating branch flap of medial vastus muscle":1,
"SW579 cell":1,
"invasion":1,
"miR-597-3p":1,
"migration":1,
"hand infection":1,
"osteomyelitis":1,
"pilomatricoma":1,
"pilomatricoma of the finger":1,
"skin neoplasm":1,
"skin tumors":1,
"cytology":1,
"fine-needle":1,
"18-FDG PET/CT":1,
"choroidal melanoma":1,
"ciliary body melanoma":1,
"uveal melanoma":1,
"NanoString":1,
"immune-related genes":1,
"oncocytic":1,
"poorly differentiated thyroid carcinoma":1,
"Thyroglobulin antibody (TgAb)":1,
"papillary thyroid carcinoma (PTC)":2,
"thyroid peroxidase antibody (TPOAb)":1,
"CASTLE":1,
"Carcinoma showing thymus-like differentiation":1,
"Carcinoma tiroideo con diferenciación similar al carcinoma tímico":1,
"Carcinoma tímico intratiroideo":1,
"Cáncer de tiroides":1,
"Intrathyroidal thymic carcinoma":1,
"Reporte de caso":1,
"facial nerve paralysis":1,
"lymphoepithelial carcinoma":1,
"salivary gland malignancy":1,
"PPAR":1,
"RXR":1,
"cluster analysis":1,
"gene expression":1,
"miRNA-27a":1,
"qRT-PCR":1,
"Neoplasm metastasis":1,
"exophthalmos":1,
"paraneoplastic syndrome":1,
"Doppler":1,
"CircRNA UMAD1":1,
"Gal3":1,
"lymph-node metastasis":1,
"miRNA-873":1,
"Manubrium":1,
"Surgery reconstruction":1,
"Differentiated thyroid carcinoma":1,
"PTEN hamartoma tumor syndrome, pediatric":1,
"Thyroid cancer genetics":1,
"Thyroid carcinoma surveillance program":1,
"SEER":1,
"sporadic MTC":1,
"metastasis-associated lung adenocarcinoma transcript 1":1,
"oncogene":1,
"regulatory cascade":1,
"tumor suppressor":1,
"tumorigenesis":1,
"Ranunculus muricatus L":1,
"acetylcholinesterase":1,
"structure elucidation":1,
"α-glucosidase":1,
"Hashimoto thyroiditis":1,
"MALT lymphoma":1,
"associations and variants":1,
"morphology":1,
"nodular Hashimoto thyroiditis":1,
"lymph node metastasis (LNM)":1,
"magnetic resonance imaging (MRI)":1,
"radiomics":1,
"ambulatory surgery":1,
"ACR TI-RADS":1,
"imaging":1,
"punctate echogenic foci":1,
"reporting system":1,
"Breast metastasis":1,
"Core needle biopsy":1,
"Hereditary breast and ovarian cancer syndrome":1,
"Peritoneal cancer":1,
"VE1 immunohistochemistry":1,
"diagnostic accuracy":1,
"sanger sequencing":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年5月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
